{"entity":{"type":"insider","cik":"0001387306","url":"/insider/0001387306","json_url":"/insider/0001387306.json","name":"Lamb Peter","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":29,"n_filings":25,"first":"2015-10-14","last":"2022-12-16","span_basis":"filed_date"},"name_variants":[{"name":"Lamb Peter","source":"filing","n_filings":25,"first_seen":"2015-10-14","last_seen":"2022-12-16"}],"transactions":[{"id":6646385,"accession":"0000939767-22-000122","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000939767-22-000122","line_url":"/filing/0000939767-22-000122#line-2","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Scientific Strategy & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Scientific Strategy & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Scientific Strategy & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":15.88,"price_display":"15.88","price_state":"stated","total_value":317600.0,"total_display":"317,600.00","total_whole":"317,600","shares_owned_after":410958.0,"shares_owned_after_display":"410,958","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2022-12-16","scope":"insider"},{"id":5040427,"accession":"0000939767-21-000115","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000939767-21-000115","line_url":"/filing/0000939767-21-000115#line-4","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Scientific Strategy & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Scientific Strategy & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Scientific Strategy & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47500.0,"shares_display":"47,500","price_per_share":17.44,"price_display":"17.44","price_state":"stated","total_value":828400.0,"total_display":"828,400.00","total_whole":"828,400","shares_owned_after":363172.0,"shares_owned_after_display":"363,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-15","filed_date":"2021-12-17","scope":"insider"},{"id":4762976,"accession":"0000939767-21-000100","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000939767-21-000100","line_url":"/filing/0000939767-21-000100#line-5","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Scientific Strategy & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Scientific Strategy & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Scientific Strategy & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47500.0,"shares_display":"47,500","price_per_share":18.09,"price_display":"18.09","price_state":"stated","total_value":859275.0,"total_display":"859,275.00","total_whole":"859,275","shares_owned_after":411240.0,"shares_owned_after_display":"411,240","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-15","filed_date":"2021-11-17","scope":"insider"},{"id":5277553,"accession":"0000939767-21-000089","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000939767-21-000089","line_url":"/filing/0000939767-21-000089#line-2","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Scientific Strategy & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Scientific Strategy & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Scientific Strategy & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47500.0,"shares_display":"47,500","price_per_share":21.92,"price_display":"21.92","price_state":"stated","total_value":1041200.0,"total_display":"1,041,200.00","total_whole":"1,041,200","shares_owned_after":411240.0,"shares_owned_after_display":"411,240","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-15","filed_date":"2021-10-15","scope":"insider"},{"id":4828439,"accession":"0000939767-21-000081","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000939767-21-000081","line_url":"/filing/0000939767-21-000081#line-2","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Scientific Strategy & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Scientific Strategy & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Scientific Strategy & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47500.0,"shares_display":"47,500","price_per_share":20.46,"price_display":"20.46","price_state":"stated","total_value":971850.0,"total_display":"971,850.00","total_whole":"971,850","shares_owned_after":389467.0,"shares_owned_after_display":"389,467","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-15","filed_date":"2021-09-17","scope":"insider"},{"id":4931098,"accession":"0000939767-21-000079","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000939767-21-000079","line_url":"/filing/0000939767-21-000079#line-2","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Scientific Strategy & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Scientific Strategy & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Scientific Strategy & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55000.0,"shares_display":"55,000","price_per_share":18.44,"price_display":"18.44","price_state":"stated","total_value":1014200.0,"total_display":"1,014,200.00","total_whole":"1,014,200","shares_owned_after":389467.0,"shares_owned_after_display":"389,467","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2021-08-18","scope":"insider"},{"id":4664013,"accession":"0000939767-21-000072","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000939767-21-000072","line_url":"/filing/0000939767-21-000072#line-2","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Scientific Strategy & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Scientific Strategy & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Scientific Strategy & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":17.47,"price_display":"17.47","price_state":"stated","total_value":1048200.0,"total_display":"1,048,200.00","total_whole":"1,048,200","shares_owned_after":389467.0,"shares_owned_after_display":"389,467","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-15","filed_date":"2021-07-16","scope":"insider"},{"id":4165454,"accession":"0000939767-21-000070","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000939767-21-000070","line_url":"/filing/0000939767-21-000070#line-2","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Scientific Strategy & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Scientific Strategy & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Scientific Strategy & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":22.18,"price_display":"22.18","price_state":"stated","total_value":1330800.0,"total_display":"1,330,800.00","total_whole":"1,330,800","shares_owned_after":389467.0,"shares_owned_after_display":"389,467","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-17","filed_date":"2021-06-22","scope":"insider"},{"id":5088376,"accession":"0000939767-21-000040","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000939767-21-000040","line_url":"/filing/0000939767-21-000040#line-2","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Scientific Strategy & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Scientific Strategy & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Scientific Strategy & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":22.96,"price_display":"22.96","price_state":"stated","total_value":1377600.0,"total_display":"1,377,600.00","total_whole":"1,377,600","shares_owned_after":389467.0,"shares_owned_after_display":"389,467","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-04-02","scope":"insider"},{"id":4269252,"accession":"0000939767-21-000029","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000939767-21-000029","line_url":"/filing/0000939767-21-000029#line-2","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Scientific Strategy & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Scientific Strategy & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Scientific Strategy & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65000.0,"shares_display":"65,000","price_per_share":22.11,"price_display":"22.11","price_state":"stated","total_value":1437150.0,"total_display":"1,437,150.00","total_whole":"1,437,150","shares_owned_after":340072.0,"shares_owned_after_display":"340,072","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"},{"id":4664004,"accession":"0000939767-21-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000939767-21-000007","line_url":"/filing/0000939767-21-000007#line-2","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Scientific Strategy & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Scientific Strategy & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Scientific Strategy & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65000.0,"shares_display":"65,000","price_per_share":22.08,"price_display":"22.08","price_state":"stated","total_value":1435200.0,"total_display":"1,435,200.00","total_whole":"1,435,200","shares_owned_after":283124.0,"shares_owned_after_display":"283,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-03","scope":"insider"},{"id":4358654,"accession":"0000939767-21-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000939767-21-000002","line_url":"/filing/0000939767-21-000002#line-2","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Scientific Strategy & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Scientific Strategy & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Scientific Strategy & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65000.0,"shares_display":"65,000","price_per_share":20.32,"price_display":"20.32","price_state":"stated","total_value":1320800.0,"total_display":"1,320,800.00","total_whole":"1,320,800","shares_owned_after":283124.0,"shares_owned_after_display":"283,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-06","scope":"insider"},{"id":2209919,"accession":"0000939767-20-000160","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000939767-20-000160","line_url":"/filing/0000939767-20-000160#line-2","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Scientific Strategy & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Scientific Strategy & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Scientific Strategy & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65000.0,"shares_display":"65,000","price_per_share":20.01,"price_display":"20.01","price_state":"stated","total_value":1300650.0,"total_display":"1,300,650.00","total_whole":"1,300,650","shares_owned_after":283124.0,"shares_owned_after_display":"283,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2954960,"accession":"0000939767-20-000103","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000939767-20-000103","line_url":"/filing/0000939767-20-000103#line-2","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Scientific Strategy & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Scientific Strategy & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Scientific Strategy & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26000.0,"shares_display":"26,000","price_per_share":22.56,"price_display":"22.56","price_state":"stated","total_value":586560.0,"total_display":"586,560.00","total_whole":"586,560","shares_owned_after":126531.0,"shares_owned_after_display":"126,531","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-08","filed_date":"2020-06-10","scope":"insider"},{"id":2102873,"accession":"0000939767-20-000070","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000939767-20-000070","line_url":"/filing/0000939767-20-000070#line-2","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Scientific Strategy & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Scientific Strategy & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Scientific Strategy & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":25.54,"price_display":"25.54","price_state":"stated","total_value":1277000.0,"total_display":"1,277,000.00","total_whole":"1,277,000","shares_owned_after":126531.0,"shares_owned_after_display":"126,531","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-07","filed_date":"2020-05-08","scope":"insider"},{"id":2420882,"accession":"0000939767-20-000047","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000939767-20-000047","line_url":"/filing/0000939767-20-000047#line-2","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Scientific Strategy & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Scientific Strategy & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Scientific Strategy & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":17.26,"price_display":"17.26","price_state":"stated","total_value":863000.0,"total_display":"863,000.00","total_whole":"863,000","shares_owned_after":126531.0,"shares_owned_after_display":"126,531","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-06","filed_date":"2020-04-08","scope":"insider"},{"id":8347556,"accession":"0000939767-19-000141","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000939767-19-000141","line_url":"/filing/0000939767-19-000141#line-7","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Scientific Strategy & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Scientific Strategy & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Scientific Strategy & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":20.67,"price_display":"20.67","price_state":"stated","total_value":2067000.0,"total_display":"2,067,000.00","total_whole":"2,067,000","shares_owned_after":117197.0,"shares_owned_after_display":"117,197","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-18","filed_date":"2019-06-19","scope":"insider"},{"id":8347548,"accession":"0000939767-19-000141","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000939767-19-000141","line_url":"/filing/0000939767-19-000141","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Scientific Strategy & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Scientific Strategy & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Scientific Strategy & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":117404.0,"shares_display":"117,404","price_per_share":20.53002487138428,"price_display":"20.53","price_state":"stated","total_value":2410307.04,"total_display":"2,410,307.04","total_whole":"2,410,307","shares_owned_after":117197.0,"shares_owned_after_display":"117,197","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-17","filed_date":"2019-06-19","scope":"insider","n_lines":2},{"id":8439311,"accession":"0000939767-19-000140","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000939767-19-000140","line_url":"/filing/0000939767-19-000140#line-2","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Scientific Strategy & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Scientific Strategy & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Scientific Strategy & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27596.0,"shares_display":"27,596","price_per_share":20.03,"price_display":"20.03","price_state":"stated","total_value":552747.88,"total_display":"552,747.88","total_whole":"552,748","shares_owned_after":117197.0,"shares_owned_after_display":"117,197","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-13","filed_date":"2019-06-14","scope":"insider"},{"id":4300217,"accession":"0000939767-17-000024","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000939767-17-000024","line_url":"/filing/0000939767-17-000024#line-3","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Scientific Strategy & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Scientific Strategy & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Scientific Strategy & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":22.19,"price_display":"22.19","price_state":"stated","total_value":998550.0,"total_display":"998,550.00","total_whole":"998,550","shares_owned_after":73600.0,"shares_owned_after_display":"73,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-01","filed_date":"2017-03-03","scope":"insider"},{"id":4693816,"accession":"0000939767-17-000009","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000939767-17-000009","line_url":"/filing/0000939767-17-000009#line-3","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Scientific Strategy & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Scientific Strategy & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Scientific Strategy & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70000.0,"shares_display":"70,000","price_per_share":18.65,"price_display":"18.65","price_state":"stated","total_value":1305500.0,"total_display":"1,305,500.00","total_whole":"1,305,500","shares_owned_after":73600.0,"shares_owned_after_display":"73,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-01","filed_date":"2017-02-03","scope":"insider"},{"id":5347824,"accession":"0000939767-17-000003","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000939767-17-000003","line_url":"/filing/0000939767-17-000003","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Scientific Strategy & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Scientific Strategy & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Scientific Strategy & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70000.0,"shares_display":"70,000","price_per_share":14.651942857142856,"price_display":"14.65","price_state":"stated","total_value":1025636.0,"total_display":"1,025,636.00","total_whole":"1,025,636","shares_owned_after":76000.0,"shares_owned_after_display":"76,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-03","filed_date":"2017-01-05","scope":"insider","n_lines":2},{"id":2821346,"accession":"0000939767-16-000286","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000939767-16-000286","line_url":"/filing/0000939767-16-000286#line-3","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Scientific Strategy & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Scientific Strategy & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Scientific Strategy & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70000.0,"shares_display":"70,000","price_per_share":16.66,"price_display":"16.66","price_state":"stated","total_value":1166200.0,"total_display":"1,166,200.00","total_whole":"1,166,200","shares_owned_after":73600.0,"shares_owned_after_display":"73,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-01","filed_date":"2016-12-02","scope":"insider"},{"id":3241740,"accession":"0000939767-16-000272","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000939767-16-000272","line_url":"/filing/0000939767-16-000272#line-3","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Scientific Strategy & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Scientific Strategy & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Scientific Strategy & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70000.0,"shares_display":"70,000","price_per_share":13.15,"price_display":"13.15","price_state":"stated","total_value":920500.0,"total_display":"920,500.00","total_whole":"920,500","shares_owned_after":73600.0,"shares_owned_after_display":"73,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-09","filed_date":"2016-11-14","scope":"insider"},{"id":8939004,"accession":"0000939767-15-000093","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000939767-15-000093","line_url":"/filing/0000939767-15-000093#line-5","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Discovery Research & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Discovery Research & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Discovery Research & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51549.0,"shares_display":"51,549","price_per_share":5.8,"price_display":"5.80","price_state":"stated","total_value":298984.2,"total_display":"298,984.20","total_whole":"298,984","shares_owned_after":36473.0,"shares_owned_after_display":"36,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-16","filed_date":"2015-10-19","scope":"insider"},{"id":8392913,"accession":"0000939767-15-000091","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000939767-15-000091","line_url":"/filing/0000939767-15-000091#line-14","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Discovery Research & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Discovery Research & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Discovery Research & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":5.8,"price_display":"5.80","price_state":"stated","total_value":3480.0,"total_display":"3,480.00","total_whole":"3,480","shares_owned_after":36473.0,"shares_owned_after_display":"36,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-13","filed_date":"2015-10-14","scope":"insider"},{"id":8392906,"accession":"0000939767-15-000091","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000939767-15-000091","line_url":"/filing/0000939767-15-000091#line-12","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001387306","owner_name":"Lamb Peter","owner_display_name":"Lamb Peter","owner_url":"/insider/0001387306","role":"Officer (EVP, Discovery Research & CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Discovery Research & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Discovery Research & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300276.0,"shares_display":"300,276","price_per_share":5.839,"price_display":"5.84","price_state":"stated","total_value":1753311.564,"total_display":"1,753,311.56","total_whole":"1,753,312","shares_owned_after":36473.0,"shares_owned_after_display":"36,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-12","filed_date":"2015-10-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":29,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":29,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":29},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000939767","name":"EXELIXIS, INC.","url":"/issuer/0000939767","role":"Officer (EVP, Scientific Strategy & CSO)","n_filings":25,"first_seen":"2015-10-14","last_seen":"2022-12-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001387306","retrieved_at":"2026-08-22T11:21:49+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}